The Lyme Disease Association Inc. is working with US Biologic to promote Lyme Disease Awareness with Biologic’s new awareness brochure and new flyer. Anyone can download and print both for free. Working together we can help to stop this disease that is affecting 476,000 people annually in the U.S. Click on the Read More below to go to the links to download the information.
Search Results for: vaccine
A peer-reviewed report co-authored by Melissa C Fesler and Raphael B Stricker has been published in the International Journal of General Medicine which evaluates pre-exposure prophylaxis (PrEP) using medications approved for use in pregnant women to prevent gestational problems and severe illness in this high-risk population.
Update 2/27/21: The FDA has approved J&J’s Covid-19 vaccine for emergency use Feb. 24, 2021 – the Food & Drug Administration (FDA) has indicated Johnson & Johnson’s COVID-19 vaccine has met requirements for emergency use authorization (EUA). The report from staff will be used to brief the Vaccines & Related Biological Products Advisory Committee meeting, […]
The Centers for Disease Control and Prevention (CDC) has provided an update in the federal agency’s Morbidity and Mortality Weekly Report (MMWR) on February 19, 2021, regarding the first month of COVID-19 vaccine safety monitoring in the US from December 14, 2020 through January 13, 2021. The report covers the two COVID-19 vaccines, developed by Pfizer BioNTech […]
The Tick-Borne Disease Working Group (TBDWG) was established by the 21st Century Cures Act to improve federal coordination of efforts related to tick-borne diseases. The TBDWG’s purpose is to review federal activities and research related to all tick-borne diseases and provide a summary of its findings and any recommendations regarding changes or improvements to such findings to the HHS Secretary and Congress every two years.
On her last day as an HHS Working Group (WG) member, after serving 2 terms, Lyme Disease Association President Pat Smith addressed at the Dec. 2 online WG meeting, her concerns about the procedures of the 2019-2020 Working Group and her concern that the interests of patients were not served by the group. Read below […]
The U.S. Department of Health and Human Services (HHS) and the Steven & Alexandra Cohen Foundation announced a
new $25 million-dollar, public-private partnership – the LymeX Innovation Accelerator (LymeX).
The HHS website states, “Our LymeX mission is to strategically advance Lyme and tickborne disease solutions in direct collaboration with Lyme patients, patient advocates, and diverse stakeholders across academia, nonprofits, industry, and government.”
The LDA is compiling a list of articles in the news & journals of possible interest regarding Covid-19 & Lyme disease. Autonomic dysfunction in ‘long COVID’: rationale, physiology and management strategies (Clinical Medicine – London) Melanie Dani, et al. Lyme Disease in the Era of COVID-19: A Delayed Diagnosis and Risk for Complications (Case Reports […]
From LDA President Pat Smith’s Blog: May is Lyme Disease Awareness Month, a time to remind ourselves that Lyme is a disease that has been neglected, minimized, and ridiculed over decades and still continues to be. We all need to redouble our efforts to get an accurate test and to get patients properly treated and treated with dignity. The continued arbitrary…
Lyme Disease Association, Inc. (LDA) has assembled articles on COVID-19 and Lyme disease to help guide you during this pandemic. Disclaimer: The Lyme Disease Association Inc. (LDA) provides this information as a public service. LDA does not necessarily endorse any of the studies or other articles in this section. Viewers need to consult with physicians […]